AR and posterior cortical atrophy: Indeed, evidence suggests that the phenomenon involving resistance to first-line therapies for metastatic PCa may be linked to several molecular networks involving AR, AR co-regulatory molecules, and lipid metabolism [13,14,15,16,17].